Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:32 PM
Ignite Modification Date:
2025-12-24 @ 1:32 PM
NCT ID:
NCT01015495
Eligibility Criteria:
Inclusion Criteria:
* Ability to provide written informed consent and comply with study assessments for the full duration of the study
* Age \> 18 years
* Angioid streaks
* Subfoveal CNV of recent onset with the following characteristics
* Absence of subfoveal fibrosis
* Fibrosis less than 25% of the lesion
* Presence of blood, subretinal fluid, and/or lipid
* New onset symptoms within 12 weeks
* Visual acuity 20/40 to 20/800 on an ETDRS chart
Exclusion Criteria:
* Prior treatment of subfoveal CNV in the study eye
* Age-related macular degeneration
* Uncontrolled glaucoma
* High myopia (\> -10.00 D spherical equivalent)
* Prior retinal detachment
* Media opacity preventing adequate view of the retina
* Planned cataract surgery in the next 3 months
* Current chemotherapy for cancer
* Immunocompromised state
* Pregnancy (positive pregnancy test) or lactation
* Premenopausal women not using adequate contraception.
* Any other condition that the investigator believes would pose a significant hazard to the subject if the investigational therapy were initiated
* Participation in another simultaneous medical investigation or trial
* History of any previous treatment for angioid streaks
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01015495
Study Brief:
Protocol Section:
NCT01015495